A phase II evaluation of lapatinib (L) and bevacizumab (B) in HER2+ metastatic breast cancer (MBC) Meeting Abstract
| Authors: | Dickler, M.; Franco, S.; Stopeck, A.; Ma, W.; Lyandres, J.; Lahiri, S.; Arbushites, M.; Koehler, M.; Rugo, H. |
| Abstract Title: | A phase II evaluation of lapatinib (L) and bevacizumab (B) in HER2+ metastatic breast cancer (MBC) |
| Meeting Title: | 33rd ESMO Congress |
| Journal Title: | Annals of Oncology |
| Volume: | 19 |
| Issue: | Suppl. 8 |
| Meeting Dates: | 2008 Sep 12-16 |
| Meeting Location: | Stockholm, Sweden |
| ISSN: | 0923-7534 |
| Publisher: | Oxford University Press |
| Date Published: | 2008-09-01 |
| Start Page: | viii65 |
| Language: | English |
| ACCESSION: | WOS:000259973300141 |
| PROVIDER: | wos |
| DOI: | 10.1093/annonc/mdn504 |
| PUBMED: | 18790885 |
| Notes: | Meeting Abstract: 141P - 33rd European-Society-for-Medical-Oncology Congress - SEP 12-16, 2008 - Stockholm, SWEDEN - "Source: Wos" |
Altmetric
Citation Impact
BMJ Impact Analytics
